You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 210566


✉ Email this page to a colleague

« Back to Dashboard


NDA 210566 describes LEXETTE, which is a drug marketed by Mayne Pharma and is included in one NDA. There are two patents protecting this drug. Additional details are available on the LEXETTE profile page.

The generic ingredient in LEXETTE is halobetasol propionate. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
Summary for 210566
Tradename:LEXETTE
Applicant:Mayne Pharma
Ingredient:halobetasol propionate
Patents:2

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.05%
Approval Date:May 24, 2018TE:ABRLD:Yes
Regulatory Exclusivity Expiration:Aug 18, 2024
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:⤷  Sign UpPatent Expiration:May 30, 2037Product Flag?Substance Flag?Delist Request?Y
Patent:⤷  Sign UpPatent Expiration:Nov 30, 2036Product Flag?YSubstance Flag?Delist Request?
Patented Use:FOR THE TOPICAL TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE AND OLDER

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.